Zacks Investment Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$271K Sell
3,178
-226
-7% -$20.1K ﹤0.01% 604
2025
Q4
$269K Buy
3,404
+20
+0.6% +$1.57K ﹤0.01% 605
2025
Q3
$271K Sell
3,384
-1,381
-29% -$118K ﹤0.01% 598
2025
Q2
$433K Sell
4,765
-628
-12% -$57.3K ﹤0.01% 505
2025
Q1
$505K Sell
5,393
-559
-9% -$50.1K ﹤0.01% 475
2024
Q4
$541K Sell
5,952
-39,272
-87% -$3.75M 0.01% 480
2024
Q3
$4.69M Buy
45,224
+40,825
+928% +$4.16M 0.04% 225
2024
Q2
$427K Buy
4,399
+821
+23% +$75.7K ﹤0.01% 468
2024
Q1
$322K Buy
3,578
+38
+1% +$3.22K ﹤0.01% 526
2023
Q4
$282K Sell
3,540
-377
-10% -$28.3K ﹤0.01% 537
2023
Q3
$279K Sell
3,917
-43,694
-92% -$3.27M ﹤0.01% 520
2023
Q2
$3.67M Buy
47,611
+43,277
+999% +$3.35M 0.05% 209
2023
Q1
$326K Sell
4,334
-85,984
-95% -$6.39M ﹤0.01% 506
2022
Q4
$7.12M Buy
90,318
+1,931
+2% +$145K 0.1% 164
2022
Q3
$6.21M Sell
88,387
-89,491
-50% -$7.02M 0.1% 155
2022
Q2
$14.3M Buy
177,878
+8,783
+5% +$687K 0.22% 108
2022
Q1
$12.8M Buy
169,095
+7,898
+5% +$626K 0.18% 124
2021
Q4
$13.8M Buy
161,197
+2,291
+1% +$179K 0.19% 122
2021
Q3
$12M Buy
158,906
+1,797
+1% +$143K 0.19% 120
2021
Q2
$12.8M Buy
157,109
+6,152
+4% +$503K 0.21% 112
2021
Q1
$11.9M Sell
150,957
-5,067
-3% -$397K 0.21% 109
2020
Q4
$13.3M Sell
156,024
-359
-0.2% -$29.7K 0.25% 108
2020
Q3
$12.1M Buy
156,383
+10,005
+7% +$763K 0.24% 104
2020
Q2
$10.7M Sell
146,378
-7,583
-5% -$539K 0.24% 100
2020
Q1
$10.2M Buy
153,961
+53,019
+53% +$3.74M 0.25% 95
2019
Q4
$6.95M Sell
100,942
-913
-0.9% -$62.2K 0.13% 130
2019
Q3
$7.49M Buy
101,855
+827
+0.8% +$60K 0.15% 124
2019
Q2
$7.24M Sell
101,028
-482
-0.5% -$34.2K 0.15% 125
2019
Q1
$6.96M Buy
101,510
+6,703
+7% +$433K 0.15% 121
2018
Q4
$5.64M Sell
94,807
-8,525
-8% -$533K 0.14% 122
2018
Q3
$6.92M Sell
103,332
-56,681
-35% -$3.78M 0.14% 124
2018
Q2
$10.4M Sell
160,013
-1,310
-0.8% -$85.7K 0.23% 100
2018
Q1
$11.6M Sell
161,323
-2,084
-1% -$150K 0.26% 93
2017
Q4
$12.3M Sell
163,407
-433
-0.3% -$31.6K 0.27% 87
2017
Q3
$11.9M Sell
163,840
-5,048
-3% -$364K 0.28% 91
2017
Q2
$12.5M Buy
168,888
+28,469
+20% +$2.11M 0.31% 85
2017
Q1
$10.3M Sell
140,419
-47,258
-25% -$3.31M 0.26% 94
2016
Q4
$12.3M Buy
187,677
+183,072
+3,976% +$12.6M 0.35% 77
2016
Q3
$341K Sell
4,605
-143
-3% -$10.6K 0.01% 484
2016
Q2
$348K Sell
4,748
-399
-8% -$28.4K 0.01% 479
2016
Q1
$364K Sell
5,147
-137,861
-96% -$9.17M 0.01% 469
2015
Q4
$9.53M Buy
143,008
+3,508
+3% +$233K 0.31% 94
2015
Q3
$8.85M Sell
139,500
-1,888
-1% -$123K 0.31% 95
2015
Q2
$9.25M Buy
141,388
+431
+0.3% +$29.2K 0.29% 99
2015
Q1
$9.77M Sell
140,957
-7,491
-5% -$518K 0.31% 101
2014
Q4
$10.3M Sell
148,448
-23,779
-14% -$1.61M 0.33% 99
2014
Q3
$11.2M Sell
172,227
-10,831
-6% -$714K 0.39% 83
2014
Q2
$12.5M Sell
183,058
-4,506
-2% -$302K 0.44% 73
2014
Q1
$12.2M Buy
187,564
+17,353
+10% +$1.09M 0.45% 79
2013
Q4
$11.1M Sell
170,211
-14,112
-8% -$903K 0.44% 88
2013
Q3
$10.9M Sell
184,323
-10,655
-5% -$631K 0.47% 78
2013
Q2
$11.2M Buy
+194,978
New +$11.6M 0.51% 75

Other funds holding CL

Zacks Investment Management's CL Position: Q1 2026 in Review

Zacks Investment Management reduced its Colgate-Palmolive (CL) stake by 6.6% in Q1 2026, selling an estimated $20.1K and leaving 3,178 shares worth $271K. The position accounts for ﹤0.01% of the portfolio, ranked #604.

Zacks Investment Management first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $14.3M in Q2 2022. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Zacks Investment Management held 3,178 shares of Colgate-Palmolive worth $271K as of Q1 2026.
  • Zacks Investment Management sold 226 Colgate-Palmolive shares in Q1 2026, an estimated $20.1K.
  • Colgate-Palmolive made up ﹤0.01% of Zacks Investment Management's portfolio in Q1 2026, its #604 holding.
  • Zacks Investment Management first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • Zacks Investment Management's Colgate-Palmolive position peaked at $14.3M in Q2 2022.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Zacks Investment Management's 13F filing for Q1 2026, filed 14 May 2026.